10-year

10-Year Anniversary Promotion (20% off)

Join GuruFocus Premium Membership Now for Only $279/Year

Once a decade discount

Save up to $500 on Global Membership.

Don't Miss It !

Free 7-day Trial
All Articles and Columns »

Weekly 52-Week Highs Highlight: COV, EQT, XLNX, TEVA

March 03, 2014 | About:
gurujx

gurujx

1 followers

According to GuruFocus list of 52-week highs, Covidien PLC, EQT Corp, Xilinx Inc. and Teva Pharmaceuticals Industries Ltd. have all reached their 52 week highs.

Covidien PLC (COV) Reached the 52-Week High of $71.95

Covidien PLC formerly known as Covidien Ltd. was incorporated in Bermuda in 2000 as a wholly-owned subsidiary of Tyco International Ltd. Covidien PLC has a market cap of $32.43 billion; its shares were traded at around $71.95 with a P/E ratio of 21.30 and P/S ratio of 3.25. The dividend yield of Covidien PLC stocks is 1.61%. Covidien PLC had an annual average earnings growth of 7.00% over the past 5 years.

Covidien PLC has released its first quarter 2014 results ended December 2013. First quarter net sales increased 3% year-over-year to $2.64 billion with operating income of $531 million versus $596 million a year ago. Diluted GAAP EPS were $0.87 versus $0.96 a year ago.

EQT Corp (EQT) Reached the 52-Week High of $102.29

EQT Corp is a Pennsylvania corporation formed in 2008 in connection with a holding company reorganization of the former Equitable Resources Inc. EQT Corp has a market cap of $15.43 billion; its shares were traded at around $102.29 with a P/E ratio of 48.10 and P/S ratio of 8.27. The dividend yield of EQT Corp stocks is 0.12%. EQT Corp had an annual average earnings growth of 11.10% over the past 10 years.

The company reported fourth quarter net income of $30.8 million and adjusted EBITDA of $36.3 million. Adjusted operating income grew 17% over last year to $30.8 million.

Xilinx Inc. (XLNX) Reached the 52-Week High of $52.20

Xilinx Inc. was founded and incorporated in California in February 1984. Xilinx Inc. has a market cap of $13.93 billion; its shares were traded at around $52.20 with a P/E ratio of 24.30 and P/S ratio of 6.43. The dividend yield of Xilinx Inc. stocks is 1.92%. Xilinx Inc. had an annual average earnings growth of 11.20% over the past 10 years. GuruFocus rated Xilinx Inc. the business predictability rank of 4-star.

Xilinx Inc. has announced its 2013 fiscal third quarter results – with sales up 15% to $587 million over the prior year quarter and net income of $176 million ($0.61 per share).

Sr. Vice President Steven L. Glaser sold 42,545 shares of XLNX stock on 02/27/2014 at the average price of $51.94. SVP WW Opertations Raja Petrakian sold 20,000 shares of XLNX stock on 02/27/2014 at the average price of $52.11.

Teva Pharmaceutical Industries Ltd. (TEVA) Reached the 52-Week High of $49.89

Teva Pharmaceutical Industries Ltd. develops, produces and markets generic, branded & OTC medicines. Teva Pharmaceutical Industries Ltd. has a market cap of $47.24 billion; its shares were traded at around $49.89 with a P/E ratio of 33.20 and P/S ratio of 2.09. The dividend yield of Teva Pharmaceutical Industries Ltd. stocks is 2.23%. Teva Pharmaceutical Industries Ltd. had an annual average earnings growth of 14.90% over the past 10 years. GuruFocus rated Teva Pharmaceutical Industries Ltd. the business predictability rank of 4.5-star.

Teva Pharmaceutical Industries has released its fourth quarter 2013 results. Total revenues were $5.4 billion for the quarter. Fourth quarter non-GAAP EPS were $1.42 and GAAP EPS were $0.45.

Check out the complete list of 52-Week Highs.


Rating: 2.0/5 (1 vote)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK